A comparative study of various dosages of danazol in the treatment of endometriosis

article OA: closed CC0 ⤵ 11 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-09

Danazol at 200 mg/day effectively treats mild endometriosis with fewer side effects, but more extensive disease necessitates higher dosages.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The results of a randomized trial to investigate the efficacy of different dosage regimens of danazol in the treatment of endometriosis indicate that for mild endometriosis 200 mg/day of danazol is adequate therapy with less severe side effects than higher dosages. However, more extensive disease requires a higher dose.

My notes (saved in your browser only)

Condition tags

dyspareuniaendometriosis

MeSH descriptors

Danazol Endometriosis Pelvic Neoplasms Pregnadienes Adult Clinical Trials as Topic Danazol Danazol Danazol Drug Administration Schedule Dyspareunia Dyspareunia Endometriosis Female Fertility Fertility Humans Menstruation Menstruation Pelvic Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (7)

Cited by (11)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:50.790931+00:00
License: CC0 · commercial use OK